Regulatory T cells, frailty, and immune activation in men who have sex with men in the multicenter AIDS cohort study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 12, 2015, Pages 1533-1541

  Zhang, Weiying ^a   Nilles, Tricia L ^a   Johnson, Jacquett R ^a   Margolick, Joseph B ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Frailty; HIV AIDS; Immune function; Infection; T cells

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; CLINICAL TRIAL; COHORT ANALYSIS; FRAIL ELDERLY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; MULTICENTER STUDY; REGULATORY T LYMPHOCYTE; SERODIAGNOSIS; SEXUAL BEHAVIOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGED; COHORT STUDIES; FRAIL ELDERLY; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SEXUAL BEHAVIOR; T-LYMPHOCYTES, REGULATORY;

EID: 84959340615     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv132     Document Type: Article

References (42)

1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-299.
2. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525-1533.
3. Effros RB, Fletcher C V, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47:542-553.
4. Martin J, Volberding P. HIV and premature aging: a feld still in its infancy. Ann Intern Med. 2010;153(7):477-499.
5. Önen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci. 2011;4(1):33-41.
6. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.
7. Fried LP, Xue QL, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64:1049-1057.
8. Chang SS, Weiss CO, Xue Q, et al. Association between infammatory-related disease burden and frailty: results from the women's health and aging studies (WHAS) I and II. Arch Gerontol Geriatr. 2012;54(1):9-15.
9. Yao X, Li H, Leng SX. Infammation and immune system alterations in frailty. Clin Geriatr Med. 2011;27:79-87.
10. Fahey JL, Schnelle J F, Boscardin J, et al. Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev. 2000;115(1-2):1-20.
11. Lederman MM, Funderburg NT, Sekaly R P, et al. Residual immune dysregu-lation syndrome in treated HIV infection. Adv Immunol. 2013;119:51-83.
12. Sakaguchi S, Miyara M, Costantino CM, et al. FOXP3(+) regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490-500.
13. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30:636-645.
14. Valencia X, Stephens G, Goldbach-Mansky R, et al. TNF downmodu-lates the function of human CD4+CD25hi T-regulatory cells. Blood. 2006;108(1):253-261.
15. Detels R, Jacobson L, Margolick J, et al. The multicenter AIDS Cohort Study, 1983 to -. Public Health. 2012;126:196-198.
16. Althoff KN, Jacobson LP, Cranston RD, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Geron-tol A Biol Sci Med Sci. 2013;69:189-198.
17. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179-1184.
18. Witt MD, Seaberg EC, Darilay A, et al. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis. 2013;57(1):77-84.
19. Hultin LE, Menendez FA, Hultin PM, et al. Assessing immunophenotyping performance: profciency-validation for adopting improved fow cytom-etry methods. Cytometry B Clin Cytom. 2007;72:249-255.
20. Roederer M. Compensation in fow cytometry. Curr Protoc Cytom. 2002;Chapter 1:Unit 1.14.
21. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, et al. TGFbeta receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med. 2013;5(195):195ra94.
22. Wagner NM, Brandhorst G, Czepluch F, et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity. 2013;21(3):461-468.
23. Losikoff P T, Self AA, Gregory SH. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. Virulence. 2012;3(7):610-620.
24. Mercer F, Kozhaya L, Unutmaz D. Expression and function of TNF and IL-1 receptors on human regulatory T cells. PLoS One. 2010;5(1):e8639.
25. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30:899-911.
26. Simonetta F, Bourgeois C. CD4+FOXP3+ regulatory T cell subsets in human immunodefciency virus (HIV) infection. Front Immunol. 2013;4:215.
27. Margolick JB, Martinez-Maza O, Jacobson L, et al. Frailty and circulating markers of infammation in HIV-infected and-uninfected men in the mul-ticenter AIDS cohort study (MACS). Presented at: The 20th Conference on Retroviruses and Opportunistic Infections; 2013; Atlanta, GA. Abstract #800.
28. Buckner JH. Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10(12):849-859.
29. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with infammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis. 2013;208:249-259.
30. Manches O, Munn D, Fallahi A, et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2, 3-dioxygenase-dependent mechanism. J Clin Invest. 2008;118:3431-3439.
31. Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, et al. Increased plasma transforming growth factor-beta1 is associated with disease progression in HIV-1-infected patients. Viral Immunol. 2004;17(1):109-113.
32. Shevach EM, Tran DQ, Davidson TS, et al. The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol. 2008;38(4):915-917.
33. Boulassel MR, Chomont N, Pai NP, et al. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29-32.
34. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121(1):29-37.
35. Wang GC, Kao WH, Murakami P, et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol. 2010;171:1144-1152.
36. Mantovani A. The growing diversity and spectrum of action of myeloid-derived suppressor cells. Eur J Immunol. 2010;40:3317-3320.
37. Raynor J, Lages CS, Shehata H, et al. Homeostasis and function of regulatory T cells in aging. Curr Opin Immunol. 2012;24(4):482-487.
38. Rosenkranz D, Weyer S, Tolosa E, et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol. 2007;188:117-127.
39. Garg SK, Delaney C, Toubai T, et al. Aging is associated with increased regulatory T-cell function. Aging Cell. 2014;13:441-448.
40. Moreno-Fernandez ME, Zapata W, Blackard JT, et al. Human regulatory T cells are targets for human immunodefciency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J Virol. 2009;83(24):12925-12933.
41. Saadoun D, Rosenzwajg M, Joly F, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med. 2011;365(22):2067-2077.
42. Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365(22):2055-2066.